The drug, which strengthens the immune system, and is administered nasally in a prophylactic scheme with a drop in each nostril twice a day for 10 days, can reduce the risk of severe symptoms in people with Covid-19,” the CIGB wrote on its Twitter account.

This preparation is an antiviral, immunomodulatory and prophylactic product, and it can be used against different acute respiratory diseases.

It is a formulation of recombinant human Alpha-2b-interferon for nasal administration, whose immunomodulatory and antiviral properties prevent the replication of the SARS-CoV-2 coronavirus, which causes Covid-19, and strengthen the immune system, the text added.

Of proven safety, this drug had a leading role when the Delta strain of the coronavirus was found in Cuba and it was necessary to increase the population’s defensive response.

jg/jav/mgt/joe